NURO Stock - NeuroMetrix, Inc.
Unlock GoAI Insights for NURO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.03M | $5.90M | $8.26M | $8.25M | $7.38M |
| Gross Profit | $1.68M | $3.95M | $5.75M | $5.92M | $5.25M |
| Gross Margin | 55.4% | 66.9% | 69.6% | 71.7% | 71.2% |
| Operating Income | $-8,782,037 | $-7,151,521 | $-4,741,766 | $-2,284,607 | $-2,094,904 |
| Net Income | $-7,806,055 | $-6,529,487 | $-4,367,218 | $-2,205,079 | $-2,002,241 |
| Net Margin | -257.4% | -110.6% | -52.9% | -26.7% | -27.1% |
| EPS | $-3.96 | $-6.27 | $-4.90 | $-0.86 | $-0.53 |
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Visit WebsiteEarnings History & Surprises
NUROEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Feb 28, 2025 | — | $-1.43 | — | — |
Q4 2024 | Nov 5, 2024 | — | $-0.75 | — | — |
Q3 2024 | Aug 6, 2024 | — | $-0.74 | — | — |
Q2 2024 | May 15, 2024 | — | $-1.67 | — | — |
Q1 2024 | Feb 22, 2024 | — | $-1.43 | — | — |
Q4 2023 | Oct 26, 2023 | — | $-1.68 | — | — |
Q3 2023 | Jul 27, 2023 | — | $-1.52 | — | — |
Q2 2023 | May 3, 2023 | — | $-1.60 | — | — |
Q1 2023 | Feb 23, 2023 | — | $-0.72 | — | — |
Q4 2022 | Oct 20, 2022 | — | $-1.84 | — | — |
Q3 2022 | Jul 21, 2022 | — | $-1.36 | — | — |
Q2 2022 | Apr 26, 2022 | — | $-1.12 | — | — |
Q1 2022 | Jan 27, 2022 | — | $-1.20 | — | — |
Q4 2021 | Oct 21, 2021 | $-1.80 | $-0.96 | +46.7% | ✓ BEAT |
Q3 2021 | Jul 22, 2021 | $-1.80 | $-1.04 | +42.2% | ✓ BEAT |
Q2 2021 | Apr 22, 2021 | $-1.80 | $-0.16 | +91.1% | ✓ BEAT |
Q1 2021 | Jan 28, 2021 | — | $-0.40 | — | — |
Q4 2020 | Oct 22, 2020 | — | $-0.56 | — | — |
Q3 2020 | Jul 23, 2020 | — | $-2.24 | — | — |
Q2 2020 | Apr 23, 2020 | — | $-3.60 | — | — |
Latest News
Frequently Asked Questions about NURO
What is NURO's current stock price?
What is the analyst price target for NURO?
What sector is NeuroMetrix, Inc. in?
What is NURO's market cap?
Does NURO pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to NURO for comparison